- ¥177bn
- ¥185bn
- ¥27bn
Brief: GNI Group announces exercise of options
Corrected: OFFICIAL-BRIEF-GNI Group to acquire Berkeley Advanced Biomaterials through GNI USA(April 18)
Brief: GNI Group to acquire Berkeley Advanced Biomaterial through GNI USA
2017 group forecast(IFRS)
2016 group results (IFRS)
2016 group forecast(IFRS)
9-MTH group results (IFRS)
Brief: GNI Group says investigational new drug approval by CFDA
Brief: GNI Group gets approval for clinical trial in China for drug of diabetic nephropathy
6-MTH group results (IFRS)
Brief: GNI Group unit gets manufacture and marketing approval of Etuary in China
Q1 group results (IFRS)
2015 group results (IFRS)
9-MTH group results